Triple

T20517943
Position Surface form Disambiguated ID Type / Status
Subject Alfred Bester E503728 entity
Predicate network P2637 FINISHED
Object PTEN NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: PTEN | Statement: [Alfred Bester, network, PTEN]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: PTEN
Context triple: [Alfred Bester, network, PTEN]
  • A. CDK4
    CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
  • B. CDK6
    CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
  • C. PTPN
    PTPN is the ICAO airport code for Pohnpei International Airport in the Federated States of Micronesia.
  • D. BRCA2 gene
    The BRCA2 gene is a human tumor suppressor gene whose mutations are strongly associated with an increased risk of breast, ovarian, and other cancers.
  • E. PLCγ2
    PLCγ2 is a phospholipase C isoform that functions as a key signaling enzyme in immune cells, mediating receptor-induced calcium mobilization and downstream activation pathways.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: PTEN
Target entity description: PTEN is a tumor suppressor gene encoding a phosphatase that negatively regulates the PI3K/AKT signaling pathway and is frequently mutated in various human cancers.
  • A. CDK4
    CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
  • B. CDK6
    CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
  • C. PTPN
    PTPN is the ICAO airport code for Pohnpei International Airport in the Federated States of Micronesia.
  • D. BRCA2 gene
    The BRCA2 gene is a human tumor suppressor gene whose mutations are strongly associated with an increased risk of breast, ovarian, and other cancers.
  • E. PLCγ2
    PLCγ2 is a phospholipase C isoform that functions as a key signaling enzyme in immune cells, mediating receptor-induced calcium mobilization and downstream activation pathways.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b4b2aa788190ae9eb37c1d73b1f1 completed April 16, 2026, 10:06 a.m.
NER Named-entity recognition batch_69e69f43e0b08190b043f35645b264a0 completed April 20, 2026, 9:48 p.m.
Created at: April 16, 2026, 11:36 a.m.